advanced search

Welcome: Guest

log in

Novo Nordisk AS Product Pipeline Analysis

Publication Date August 2008
Publisher Global Markets Direct
Product Type Report
Pages 40
ISBN Number not applicable
Product Code GMD04857
Buy this product or for assistance call +44 20 7060 7474

Summary

This report is an insightful source for data, analysis and strategic insights into a Novo Nordisk AS's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook In Vitro Diagnostics
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 Competitors
  • 6 Key Employees
  • 7 Key Employee Biographies
  • 8 Company Statement
  • 9 Locations And Subsidiaries
    • 9.1 Head Office
    • 9.2 Other Locations & Subsidiaries
  • 10 Recent Developments
    • 10.1 Financial Announcements
      • 10.1.1 Aug 07, 2008: Novo Reports 1H 2008 Results
      • 10.1.2 Apr 30, 2008: Novo Reports Q1 2008 Results
      • 10.1.3 Jan 31, 2008: Novo Reports 2007 Results
      • 10.1.4 Oct 31, 2007: Novo Declares Nine Months Ended 2007 Results
      • 10.1.5 Aug 03, 2007: Novo Reports H1 2007 Results
      • 10.1.6 May 02, 2007: Novo Reports Q1 2007 Results
      • 10.1.7 Jan 31, 2007: Novo Reports 2006 Results
    • 10.2 Product News
      • 10.2.1 Sep 11, 2001: InDuo Is Launched To Help Improve Diabetes Management
  • 11 Novo Nordisk A/S Pipeline Products
    • 11.1 Novo Nordisk A/S Product Pipeline Analysis
      • 11.1.1 Novo Nordisk A/S Pipeline Products By Equipment Type
      • 11.1.2 Novo Nordisk A/S Pipeline Products By Development Stage
      • 11.1.3 Novo Nordisk A/S Pipeline Products By Therapy Area
    • 11.2 Future Inhalation Systems
      • 11.2.1 Product Description
      • 11.2.2 Product Status
    • 11.3 Future Insulin Infusion Systems
      • 11.3.1 Product Description
      • 11.3.2 Product Status
    • 11.4 Next Generation Durable Pen
      • 11.4.1 Product Description
      • 11.4.2 Product Status
    • 11.5 Next Generation Needles
      • 11.5.1 Product Description
      • 11.5.2 Product Status
  • 12 Appendix
    • 12.1 Methodology
      • 12.1.1 Coverage
      • 12.1.2 Secondary Research
      • 12.1.3 Primary Research
      • 12.1.4 Expert Panel Validation
    • 12.2 Contact Us
    • 12.3 About Global Markets Direct
    • 12.4 Disclaimer
  • 1 List of Tables
    • Table 1: Novo Nordisk A/S,Key Facts
    • Table 2: Novo Nordisk A/S, Key Employees,
    • Table 3: Novo Nordisk A/S, Other Locations
    • Table 4: Novo Nordisk A/S, Subsidiaries
    • Table 5: Novo Nordisk A/S Pipeline Products by Equipment Type
    • Table 6: Novo Nordisk A/S Pipeline Products By Development Stage
    • Table 7: Novo Nordisk A/S Pipeline Products By Therapy Area
    • 1.2 List of Figures
    • Figure 1: Novo Nordisk A/S Pipeline Products By Development Stage
    • Figure 2: Global Markets Direct Methodology
Product features / use
Scope Expert Insight/Opinion yes
Profiles In-depth Company Insight yes
Features Primary Research Data yes

Industry Events

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>